Acutus Medical (NASDAQ:AFIB) Reaches New 12-Month Low at $22.15

Acutus Medical, Inc. (NASDAQ:AFIB)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $22.15 and last traded at $22.35, with a volume of 3929 shares. The stock had previously closed at $23.22.

A number of research analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of Acutus Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, January 19th. Bank of America cut shares of Acutus Medical from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $38.00 to $30.00 in a report on Thursday, January 14th. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $30.00 price objective on shares of Acutus Medical in a report on Thursday, January 14th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $34.75.

The company has a debt-to-equity ratio of 0.25, a quick ratio of 10.21 and a current ratio of 10.89. The firm has a fifty day moving average price of $26.56.

Several hedge funds have recently added to or reduced their stakes in AFIB. Citigroup Inc. increased its holdings in shares of Acutus Medical by 366.1% in the 4th quarter. Citigroup Inc. now owns 2,200 shares of the company’s stock worth $63,000 after acquiring an additional 1,728 shares during the period. Strs Ohio acquired a new position in Acutus Medical during the 3rd quarter valued at about $74,000. JPMorgan Chase & Co. acquired a new position in Acutus Medical during the 3rd quarter valued at about $116,000. Morgan Stanley acquired a new position in Acutus Medical during the 3rd quarter valued at about $127,000. Finally, American International Group Inc. acquired a new position in Acutus Medical during the 3rd quarter valued at about $175,000. 69.56% of the stock is currently owned by institutional investors and hedge funds.

Acutus Medical Company Profile (NASDAQ:AFIB)

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. It offers AcQMap console and workstation, an advanced imaging, navigation, and mapping system for physicians to map, treat, re-map, and adjust additional therapy as needed; and Patient Electrode Kit that is required in every procedure to provide cardiac signals, catheter localization, and AcQMap system grounding.

Further Reading: What does an outperform rating mean?

Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.